Kumar et al. observed that administration of anti-MIF-inhibiting antibody inhibited the production of CD14+/HLA-DR-MDSCs stimulated by glioma-conditioned media (GCM) in their experimental models [36]. Here, MIF is linked to central nervous system cancer.